STAY UPDATED

We are committed to sharing the latest news and activities related to HDx therapy enabled by the THERANOVA dialyzer. Check out the latest news and events below.

berliner.png
Event

BDS Berliner Dialyseseminar

The BDS deals with latest topics of renal replacement therapy and the diseases of dialysis patients. The focus is on continuing education, especially for internists specializing in nephrology and physicians, but also doctors of other disciplines and nurses and to inform about interesting and current issues. Participants have the opportunity to actively participate using a TED voting system. The event has grown steadily since 1988 and has become a permanent institution for nephrologists from all over Germany, Austria and Switzerland.

VISIT EVENT WEBSITE
Berlin
close

Available now - you are invited to view a presentation showcasing the latest advances in hemodialysis membrane technology: patient centred care

Filmed at a recent Symposium at Perth, proudly sponsored by Baxter Healthcare, Professor Colin Hutchison and Dr Markus Storr explore:

  • Middle molecules and the impact to the patient
  • The advances of mid cut off membrane technology designed for the removal of middle molecules
  • The relevance to dialysis today

PROFESSOR

COLIN HUTCHINSON

Hawkes Bay District
Health Board, New Zealand Professor Colin Hutchison is the Director of Nephrology and Head of Medicine at Hawke’s Bay District Health Board Hastings, New Zealand. Professor Colin Hutchison talks about the latest research in middle molecule evidence, and our current capacity to clear with dialysis.

DR MARKUS STORR

Baxter Healthcare
Hechingen, Germany
Markus Storr is a senior manager at Baxter’s Research and Development Department in Hechingen, Germany. Dr Markus Storr, outlines the methods of middle molecule removal, current and future innovations with enhanced selectivity.

Presentation available now - log in or sign up to www.baxterprofessional.com.au

RSA_Australasia.jpg
Event

RSA Annual Conference

The theme for the annual conference is, “Renal care in a changing environment: Innovation and transformation”. We look forward to invite attendees to our Baxter booth and innovation room to discover the potential of our HDx therapy - the next innovation in hemodialysis therapy. We will also host a dinner symposium the day before discussing the latest advances in hemodialysis membrane technology: patient centered care with professor Colin Hutchison, Hawke’s Bay District Health Board, New Zealand. To register for this event, please log on to Baxter Professional and navigate to events. Registrations are limited. RSVP: 2nd June, 2017.

VISIT EVENT WEBSITE
SYDNEY
close

Available now - you are invited to view a presentation showcasing the latest advances in hemodialysis membrane technology: patient centred care

Filmed at a recent Symposium at Perth, proudly sponsored by Baxter Healthcare, Professor Colin Hutchison and Dr Markus Storr explore:

  • Middle molecules and the impact to the patient
  • The advances of mid cut off membrane technology designed for the removal of middle molecules
  • The relevance to dialysis today

PROFESSOR

COLIN HUTCHINSON

Hawkes Bay District
Health Board, New Zealand Professor Colin Hutchison is the Director of Nephrology and Head of Medicine at Hawke’s Bay District Health Board Hastings, New Zealand. Professor Colin Hutchison talks about the latest research in middle molecule evidence, and our current capacity to clear with dialysis.

DR MARKUS STORR

Baxter Healthcare
Hechingen, Germany
Markus Storr is a senior manager at Baxter’s Research and Development Department in Hechingen, Germany. Dr Markus Storr, outlines the methods of middle molecule removal, current and future innovations with enhanced selectivity.

Presentation available now - log in or sign up to www.baxterprofessional.com.au

Nordic_event.jpg
Event

Kongress für Nephrologie

Visit our Booth and Symposia at the 9th annual congress of the German Society of Nephrology.

VISIT EVENT WEBSITE
Mannheim
close

Available now - you are invited to view a presentation showcasing the latest advances in hemodialysis membrane technology: patient centred care

Filmed at a recent Symposium at Perth, proudly sponsored by Baxter Healthcare, Professor Colin Hutchison and Dr Markus Storr explore:

  • Middle molecules and the impact to the patient
  • The advances of mid cut off membrane technology designed for the removal of middle molecules
  • The relevance to dialysis today

PROFESSOR

COLIN HUTCHINSON

Hawkes Bay District
Health Board, New Zealand Professor Colin Hutchison is the Director of Nephrology and Head of Medicine at Hawke’s Bay District Health Board Hastings, New Zealand. Professor Colin Hutchison talks about the latest research in middle molecule evidence, and our current capacity to clear with dialysis.

DR MARKUS STORR

Baxter Healthcare
Hechingen, Germany
Markus Storr is a senior manager at Baxter’s Research and Development Department in Hechingen, Germany. Dr Markus Storr, outlines the methods of middle molecule removal, current and future innovations with enhanced selectivity.

Presentation available now - log in or sign up to www.baxterprofessional.com.au

Nordic_event.jpg
Event

Nordic Society of Nephrology

The Congress will be a great opportunity for participants to meet and discuss topics within nephrology and to further increase the co-operation between colleagues from our Nordic countries. Talk to our Baxter representatives at the Congress to learn more about HDx Therapy and how this new Therapy can benefit your patients.

VISIT EVENT WEBSITE
MALMÖ
close

Available now - you are invited to view a presentation showcasing the latest advances in hemodialysis membrane technology: patient centred care

Filmed at a recent Symposium at Perth, proudly sponsored by Baxter Healthcare, Professor Colin Hutchison and Dr Markus Storr explore:

  • Middle molecules and the impact to the patient
  • The advances of mid cut off membrane technology designed for the removal of middle molecules
  • The relevance to dialysis today

PROFESSOR

COLIN HUTCHINSON

Hawkes Bay District
Health Board, New Zealand Professor Colin Hutchison is the Director of Nephrology and Head of Medicine at Hawke’s Bay District Health Board Hastings, New Zealand. Professor Colin Hutchison talks about the latest research in middle molecule evidence, and our current capacity to clear with dialysis.

DR MARKUS STORR

Baxter Healthcare
Hechingen, Germany
Markus Storr is a senior manager at Baxter’s Research and Development Department in Hechingen, Germany. Dr Markus Storr, outlines the methods of middle molecule removal, current and future innovations with enhanced selectivity.

Presentation available now - log in or sign up to www.baxterprofessional.com.au

event-nephro-swiss.jpg
Event

Italian Society of Nephrology Annual Congress (SIN)

The Italian Society of Nephrology (SIN), established in 1980, has objectives of general interest and social utility to promote and enhance the field of Nephrology in all its aspects. Join us at this year’s Congress to find out more about HDx Therapy.

VISIT EVENT WEBSITE
RIMINI
close

Available now - you are invited to view a presentation showcasing the latest advances in hemodialysis membrane technology: patient centred care

Filmed at a recent Symposium at Perth, proudly sponsored by Baxter Healthcare, Professor Colin Hutchison and Dr Markus Storr explore:

  • Middle molecules and the impact to the patient
  • The advances of mid cut off membrane technology designed for the removal of middle molecules
  • The relevance to dialysis today

PROFESSOR

COLIN HUTCHINSON

Hawkes Bay District
Health Board, New Zealand Professor Colin Hutchison is the Director of Nephrology and Head of Medicine at Hawke’s Bay District Health Board Hastings, New Zealand. Professor Colin Hutchison talks about the latest research in middle molecule evidence, and our current capacity to clear with dialysis.

DR MARKUS STORR

Baxter Healthcare
Hechingen, Germany
Markus Storr is a senior manager at Baxter’s Research and Development Department in Hechingen, Germany. Dr Markus Storr, outlines the methods of middle molecule removal, current and future innovations with enhanced selectivity.

Presentation available now - log in or sign up to www.baxterprofessional.com.au
www.baxterprofessional.co.nz

event-nephro-swiss.jpg
Event

ASN Kidney week

Visit us the annual ASN congress to learn more what’s next in renal therapies.

VISIT EVENT WEBSITE
NEW ORLEANS, LOUISIANA
close

Available now - you are invited to view a presentation showcasing the latest advances in hemodialysis membrane technology: patient centred care

Filmed at a recent Symposium at Perth, proudly sponsored by Baxter Healthcare, Professor Colin Hutchison and Dr Markus Storr explore:

  • Middle molecules and the impact to the patient
  • The advances of mid cut off membrane technology designed for the removal of middle molecules
  • The relevance to dialysis today

PROFESSOR

COLIN HUTCHINSON

Hawkes Bay District
Health Board, New Zealand Professor Colin Hutchison is the Director of Nephrology and Head of Medicine at Hawke’s Bay District Health Board Hastings, New Zealand. Professor Colin Hutchison talks about the latest research in middle molecule evidence, and our current capacity to clear with dialysis.

DR MARKUS STORR

Baxter Healthcare
Hechingen, Germany
Markus Storr is a senior manager at Baxter’s Research and Development Department in Hechingen, Germany. Dr Markus Storr, outlines the methods of middle molecule removal, current and future innovations with enhanced selectivity.

Presentation available now - log in or sign up to www.baxterprofessional.com.au
www.baxterprofessional.co.nz

event-nephro-swiss.jpg
Event

SGN-SSN
Swiss Society of Nephrology

The 48th annual meeting of the Swiss Society of Nephrology will be another opportunity to find out more on the new HDx therapy.

VISIT EVENT WEBSITE
Interlaken
close

Available now - you are invited to view a presentation showcasing the latest advances in hemodialysis membrane technology: patient centred care

Filmed at a recent Symposium at Perth, proudly sponsored by Baxter Healthcare, Professor Colin Hutchison and Dr Markus Storr explore:

  • Middle molecules and the impact to the patient
  • The advances of mid cut off membrane technology designed for the removal of middle molecules
  • The relevance to dialysis today

PROFESSOR

COLIN HUTCHINSON

Hawkes Bay District
Health Board, New Zealand Professor Colin Hutchison is the Director of Nephrology and Head of Medicine at Hawke’s Bay District Health Board Hastings, New Zealand. Professor Colin Hutchison talks about the latest research in middle molecule evidence, and our current capacity to clear with dialysis.

DR MARKUS STORR

Baxter Healthcare
Hechingen, Germany
Markus Storr is a senior manager at Baxter’s Research and Development Department in Hechingen, Germany. Dr Markus Storr, outlines the methods of middle molecule removal, current and future innovations with enhanced selectivity.

Presentation available now - log in or sign up to www.baxterprofessional.com.au
www.baxterprofessional.co.nz

Swiss Launch image
News

Expanded Hemodialysis Innovative Clinical Approach in Dialysis

close

This book by C. Ronco contains emerging evidence and fascinating new hypotheses on HDx. It is highly recommended for all physicians and healthcare professionals who are caring for dialysis patients and are seeking innovation and improved care solutions. The material is available on-line for free by downloading the individual chapters (available in PDF format). Read more here.

Reference: DOI: 10.1159/000479262

Sign up

Keep up to date with all our latest news, stories and events. By subscribing, you can learn more about our innovative therapy program, ongoing trials and results, and global research partnerships. Delivered right to your inbox.